90 related articles for article (PubMed ID: 23155255)
21. Enhancement of radiosensitivity in head and neck cancer cells by ZD1839 ('IRESSA'), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
Shintani S; Kiyota A; Mihara M; Sumida T; Kayahara H; Nakashiro K; Hamakawa H
Am J Clin Oncol; 2003 Oct; 26(5):e150-6. PubMed ID: 14528090
[TBL] [Abstract][Full Text] [Related]
22. Effect of small interfering RNA targeting hypoxia-inducible factor-1α on radiosensitivity of PC3 cell line.
Huang Y; Yu J; Yan C; Hou J; Pu J; Zhang G; Fu Z; Wang X
Urology; 2012 Mar; 79(3):744.e17-24. PubMed ID: 22196409
[TBL] [Abstract][Full Text] [Related]
23. Marsdenia tenacissima extract restored gefitinib sensitivity in resistant non-small cell lung cancer cells.
Han SY; Zhao MB; Zhuang GB; Li PP
Lung Cancer; 2012 Jan; 75(1):30-7. PubMed ID: 21757251
[TBL] [Abstract][Full Text] [Related]
24. Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab.
Jing Z; Gong L; Xie CY; Zhang L; Su HF; Deng X; Wu SX
Radiother Oncol; 2009 Dec; 93(3):468-73. PubMed ID: 19744737
[TBL] [Abstract][Full Text] [Related]
25. Enediyne lidamycin enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib, in epidermoid carcinoma A431 cells and lung carcinoma H460 cells.
Liu H; Li L; Li XQ; Liu XJ; Zhen YS
Anticancer Drugs; 2009 Jan; 20(1):41-9. PubMed ID: 19342999
[TBL] [Abstract][Full Text] [Related]
26. Interaction of ionizing radiation and ZRBA1, a mixed EGFR/DNA-targeting molecule.
Heravi M; Rachid Z; Goudarzi A; Schlisser A; Jean-Claude BJ; Radzioch D; Muanza TM
Anticancer Drugs; 2009 Sep; 20(8):659-67. PubMed ID: 19581798
[TBL] [Abstract][Full Text] [Related]
27. Radiosensitizing effects of gefitinib at different administration times in vitro.
Zhuang HQ; Sun J; Yuan ZY; Wang J; Zhao LJ; Wang P; Ren XB; Wang CL
Cancer Sci; 2009 Aug; 100(8):1520-5. PubMed ID: 19432883
[TBL] [Abstract][Full Text] [Related]
28. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
29. Lapatinib, a Dual Inhibitor of Epidermal Growth Factor Receptor (EGFR) and HER-2, Enhances Radiosensitivity in Mouse Bladder Tumor Line-2 (MBT-2) Cells In Vitro and In Vivo.
Mu Y; Sun D
Med Sci Monit; 2018 Aug; 24():5811-5819. PubMed ID: 30125265
[TBL] [Abstract][Full Text] [Related]
30. Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways.
Sordella R; Bell DW; Haber DA; Settleman J
Science; 2004 Aug; 305(5687):1163-7. PubMed ID: 15284455
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer.
Dominguez-Escrig JL; Kelly JD; Neal DE; King SM; Davies BR
Clin Cancer Res; 2004 Jul; 10(14):4874-84. PubMed ID: 15269164
[TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor receptor activity determines response of colorectal cancer cells to gefitinib alone and in combination with chemotherapy.
Van Schaeybroeck S; Karaiskou-McCaul A; Kelly D; Longley D; Galligan L; Van Cutsem E; Johnston P
Clin Cancer Res; 2005 Oct; 11(20):7480-9. PubMed ID: 16243822
[TBL] [Abstract][Full Text] [Related]
33. Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor.
Mantha AJ; Hanson JE; Goss G; Lagarde AE; Lorimer IA; Dimitroulakos J
Clin Cancer Res; 2005 Mar; 11(6):2398-407. PubMed ID: 15788691
[TBL] [Abstract][Full Text] [Related]
34. [Radiosensitizing effect of erlotinib on human lung adenocarcinoma cell line A549].
Liu XQ; Qiao TK
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):819-23. PubMed ID: 24447478
[TBL] [Abstract][Full Text] [Related]
35. Cyclopamine increases the radiosensitivity of human pancreatic cancer cells by regulating the DNA repair signal pathway through an epidermal growth factor receptor‑dependent pathway.
Wu XY; Che J; Sun KK; Shen XJ; Yang D; Zhong N; Zhao H
Mol Med Rep; 2013 Oct; 8(4):979-83. PubMed ID: 23903906
[TBL] [Abstract][Full Text] [Related]
36. [Effects and its mechanism of Nimotuzumab on radiosensitivity of esophageal carcinoma ECA-109 and TE-13 cell lines].
Wang J; Wang W; Guo Y; Jing SW; Shang K; Miao MC; Wang J; Wu YJ; Liu LN; Yu JM
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):732-738. PubMed ID: 27784455
[No Abstract] [Full Text] [Related]
37. Metabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: an in vitro study.
Colen CB; Seraji-Bozorgzad N; Marples B; Galloway MP; Sloan AE; Mathupala SP
Neurosurgery; 2006 Dec; 59(6):1313-23; discussion 1323-4. PubMed ID: 17277695
[TBL] [Abstract][Full Text] [Related]
38. [Effect of platycodin D on radiosensitivity of human hepatoma cell line and related mechanisms of action].
Zhu CG; Zhang LS
Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):458-462. PubMed ID: 28763865
[No Abstract] [Full Text] [Related]
39. [Gefitinib enhances the radiosensitivity of nasopharyngeal carcinoma cell line CNE2 in vitro].
He BF; Sun AM; Huang BY; Wang WJ; Zheng XK; Luo RC
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(6):991-4. PubMed ID: 21690052
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of radiosensitivity by roscovitine pretreatment in human non-small cell lung cancer A549 cells.
Zhang F; Zhang T; Gu ZP; Zhou YA; Han Y; Li XF; Wang XP; Cheng QS; Mei QB
J Radiat Res; 2008 Sep; 49(5):541-8. PubMed ID: 18728343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
